Key Findings

The study characterizes a novel IMP-28 metallo-beta-lactamase from a Spanish Klebsiella oxytoca clinical isolate, demonstrating its lower hydrolytic capacity compared to IMP-1, primarily due to the His306Gln mutation affecting substrate accessibility and hydrolysis.